Coppell Advisory Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Coppell Advisory Solutions's VRTX Position: Q2 2026 in Review
Coppell Advisory Solutions opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 436 shares worth $1.68M. The stake represents 0.14% of the portfolio and ranks #131 among its holdings. This is a return to the name: Coppell Advisory Solutions previously reported a position in VRTX as recently as Q2 2025.
Coppell Advisory Solutions first reported a position in VRTX in Q4 2022 and has held it in 10 quarters since. The position peaked at $2.95M in Q2 2025. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Coppell Advisory Solutions held 436 shares of Vertex Pharmaceuticals worth $1.68M as of Q2 2026.
- Vertex Pharmaceuticals was a new Coppell Advisory Solutions position in Q2 2026.
- Vertex Pharmaceuticals made up 0.14% of Coppell Advisory Solutions's portfolio in Q2 2026, its #131 holding.
- Coppell Advisory Solutions first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 10 quarters since.
- Coppell Advisory Solutions's Vertex Pharmaceuticals position peaked at $2.95M in Q2 2025.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Coppell Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.